References
- Iida K, Naiki T, Naiki-Ito A, Suzuki S, Kato H, Nozaki S, Nagai T, Etani T, Nagayasu Y, Ando R, et al. Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway. Cancer Sci. 2020;111(4):1165–79. doi:https://doi.org/10.1111/cas.14334
- El-Ashmawy NE, Khedr EG, El-Bahrawy HA, Al-Tantawy SM. Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer. Tumour Biol. 2017;39(2):1010428317692254. doi:https://doi.org/10.1177/1010428317692254
- Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–41. doi:https://doi.org/10.1016/j.eururo.2012.07.033
- Guillaume L, Guy L. Epidemiology of and risk factors for bladder cancer and for urothelial tumors. Rev Prat. 2014;64:1378–80.
- Parada B, Reis F, Pinto A, Sereno J, Xavier-Cunha M, Neto P, Rocha-Pereira P, Mota A, Figueiredo A, Teixeira F, et al. Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties. Int J Mol Sci. 2012;13(7):8482–99. doi:https://doi.org/10.3390/ijms13078482
- Hameed DA, el-Metwally TH. The effectiveness of retinoic acid treatment in bladder cancer: impact on recurrence, survival and TGFalpha and VEGF as end-point biomarkers. Cancer Biol Ther. 2008;7(1):92–100. doi:https://doi.org/10.4161/cbt.7.1.5134
- Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr. 1999;129(3):775S–8S. doi:https://doi.org/10.1093/jn/129.3.775S
- Murali R, Saravanan R. Antidiabetic effect of d-limonene, a monoterpene in streptozotocin-induced diabetic rats. Biomed Prevent Nutrit. 2012;2(4):269–75. doi:https://doi.org/10.1016/j.bionut.2012.08.008
- Rathinam A, Pari L, Venkatesan M, Munusamy S. Myrtenal attenuates oxidative stress and inflammation in a rat model of streptozotocin-induced diabetes. Arch Physiol Biochem. 2019;:1–9. doi:https://doi.org/10.1080/13813455.2019.1670212
- Babu LH, Perumal S, Balasubramanian MP. Myrtenal, a natural monoterpene, down-regulates TNF-α expression and suppresses carcinogen-induced hepatocellular carcinoma in rats. Mol Cell Biochem. 2012;369(1-2):183–93. doi:https://doi.org/10.1007/s11010-012-1381-0
- Kaufmann D, Dogra AK, Wink M. Myrtenal inhibits acetylcholinesterase, a known Alzheimer target. J Pharm Pharmacol. 2011;63(10):1368–71. doi:https://doi.org/10.1111/j.2042-7158.2011.01344.x
- Rathinam A, Pari L, Chandramohan R, Sheikh BA. Histopathological findings of the pancreas, liver, and carbohydrate metabolizing enzymes in STZ-induced diabetic rats improved by administration of myrtenal. J Physiol Biochem. 2014;70(4):935–46. doi:https://doi.org/10.1007/s13105-014-0362-z
- Ayyasamy R, Leelavinothan P. Myrtenal alleviates hyperglycaemia, hyperlipidaemia and improves pancreatic insulin level in STZ-induced diabetic rats. Pharm Biol. 2016;54(11):2521–7. doi:https://doi.org/10.3109/13880209.2016.1168852
- Ito N. Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. Cancer Res. 1976;36(7 PT 2):2528–31.
- Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol. 1979;135(3):372–6. doi:https://doi.org/10.1016/0002-9378(79)90708-7
- Montgomery H, Dymock JF. The rapid determination of nitrate in fresh and saline waters. Analyst. 1962;87(1034):374–8. doi:https://doi.org/10.1039/an9628700374
- Kettle AJ, Winterbourn CC. Assays for the chlorination activity of myeloperoxidase. Methods Enzymol. 1994;233:502–12. doi:https://doi.org/10.1016/s0076-6879(94)33056-5
- Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45. doi:https://doi.org/10.1093/nar/29.9.e45
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–8. doi:https://doi.org/10.1006/meth.2001.1262
- Bancroft JD, Stevens A. 1990. Theory and practice of histological techniques. 3rd ed. Edinburgh: Churchill Livingstone.
- Oyasu R. World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors. Cancer. 2000;88(7):1509–12. doi:https://doi.org/10.1002/(sici)1097-0142(20000401)88:7<1509::aid-cncr1>3.0.co;2-g
- Prabhu B, Balakrishnan D, Sundaresan S. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats. Hum Exp Toxicol. 2016;35(6):685–92. doi:https://doi.org/10.1177/0960327115597985
- Vasconcelos-Nóbrega C, Colaço A, Lopes C, Oliveira PA. Review: BBN as an urothelial carcinogen. In Vivo. 2012;26(4):727–39.
- Greenberger JS, Anderson J, Berry LA, Epperly M, Cronkite EP, Boggs SS. Effects of irradiation of CBA/CA mice on hematopoietic stem cells and stromal cells in long-term bone marrow cultures. Leukemia. 1996;10(3):514–27.
- Oliveira PA, Palmeira C, Colaço A, de la Cruz LF, Lopes C. DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin. Anticancer Res. 2006;26:2995–3004.
- Oliveira M, Nascimento-Gonçalves E, Silva J, Oliveira PA, Ferreira R, et al. Implementation of humane endpoints in a urinary bladder carcinogenesis study in rats. In Vivo. 2017;31:1073–80.: doi:https://doi.org/10.21873/invivo.11172
- Parada B, Reis F, Cerejo R, Garrido P, Sereno J, Xavier-Cunha M, Neto P, Mota A, Figueiredo A, Teixeira F, et al. Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer. Biomed Res Int. 2013;2013:368178.: doi:https://doi.org/10.1155/2013/368178.
- Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89(2):381–410. doi:https://doi.org/10.1152/physrev.00016.2008
- Sivaramakrishnan V, Shilpa PN, Praveen Kumar VR, Niranjali Devaraj S. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chem Biol Interact. 2008;171(1):79–88. doi:https://doi.org/10.1016/j.cbi.2007.09.003
- Singh BN, Singh BR, Sarma BK, Singh HB. Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark. Chem Biol Interact. 2009;181(1):20–8. doi:https://doi.org/10.1016/j.cbi.2009.05.007
- Adeleke GE, Adaramoye OA. Betulinic acid protects against N-nitrosodimethylamine-induced redox imbalance in testes of rats. Redox Rep. 2017;22(6):556–62. doi:https://doi.org/10.1080/13510002.2017.1322750
- Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51(1):27–41. doi:https://doi.org/10.1016/j.immuni.2019.06.025
- Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204–18. doi:https://doi.org/10.18632/oncotarget.23208
- Hendrayani SF, Al-Harbi B, Al-Ansari MM, Silva G, Aboussekhra A. The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. Oncotarget. 2016;7(27):41974–85. doi:https://doi.org/10.18632/oncotarget.9633
- Lokeshkumar B, Thamaraiselvan R, Mathiwos D, Balasubramanian MP. Anti-inflammatory effect of myrtenal against cytokines in experimental colon cancer. Aust J Sci Technol. 2017;1:11–6.
- Dragomanova S, Tancheva L, Georgieva M. A review: Biological activity of myrtenal and some myrtenal-containing medicinal plant essential oils. Scr Sci Pharm. 2018;5(2):22–33. doi:https://doi.org/10.14748/ssp.v5i2.5614
- Thanan R, Murata M, Ma N, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Oikawa S, Kawanishi S. Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediators Inflamm. 2012;2012:165879 doi:https://doi.org/10.1155/2012/165879
- Bourn J, Rathore K, Donnell R, White W, Uddin MJ, Marnett L, Cekanova M. Detection of carcinogen-induced bladder cancer by fluorocoxib A. BMC Cancer. 2019;19(1):1152 doi:https://doi.org/10.1186/s12885-019-6366-x
- Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis. 2000;21(2):139–46.: doi:https://doi.org/10.1093/carcin/21.2.139
- Desai SJ, Prickril B, Rasooly A. Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer. Nutr Cancer. 2018;70(3):350–75. doi:https://doi.org/10.1080/01635581.2018.1446091
- Kamat AM, Tharakan ST, Sung B, Aggarwal BB. Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors. Cancer Res. 2009;69(23):8958–66. doi:https://doi.org/10.1158/0008-5472.CAN-09-2045
- Li J, Qu W, Cheng Y, Sun Y, Jiang Y, Zou T, Wang Z, Xu Y, Zhao H. The inhibitory effect of intravesical fisetin against bladder cancer by induction of p53 and down-regulation of NF-kappa B pathways in a rat bladder carcinogenesis model. Basic Clin Pharmacol Toxicol. 2014;115(4):321–9. doi:https://doi.org/10.1111/bcpt.12229
- Levidou G, Saetta AA, Korkolopoulou P, Papanastasiou P, Gioti K, Pavlopoulos P, Diamantopoulou K, Thomas-Tsagli E, Xiromeritis K, Patsouris E, et al. Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder. Virchows Arch. 2008;452(3):295–304.:doi:https://doi.org/10.1007/s00428-007-0560-y
- Ito Y, Kikuchi E, Tanaka N, Kosaka T, Suzuki E, Mizuno R, Shinojima T, Miyajima A, Umezawa K, Oya M, et al. Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer. BMC Cancer. 2015;15(1):324.: doi:https://doi.org/10.1186/s12885-015-1315-9
- Wonganan O, He Y-J, Shen X-F, Wongkrajang K, Suksamrarn A, Zhang G-L, Wang F. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells. Toxicol Appl Pharmacol. 2017;336:31–9. doi:https://doi.org/10.1016/j.taap.2017.10.004
- Booupathy LK, Venkatachalam S, Natarajan N, Thamaraiselvan R, Arumugam M, Maruthaiveeran Periyasamy B. Chemopreventive effect of myrtenal on bacterial enzyme activity and the development of 1,2-dimethyl hydrazine-induced aberrant crypt foci in Wistar Rats. J Food Drug Anal. 2016;24(1):206–13. doi:https://doi.org/10.1016/j.jfda.2015.07.003
- Wattenberg LW, Borchert P, Destafney CM, Coccia JB. Effects of p-methoxyphenol and diet on carcinogen-induced neoplasia of the mouse forestomach. Cancer Res. 1983;43(10):4747–51.
- Gong J, Xie J, Bedolla R, Rivas P, Chakravarthy D, Freeman JW, Reddick R, Kopetz S, Peterson A, Wang H, et al. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Clin Cancer Res. 2014;20(5):1259–73.:doi:https://doi.org/10.1158/1078-0432.ccr-13-1664
- Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 1997;275(5302):967–9. doi:https://doi.org/10.1126/science.275.5302.967
- Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435(7042):677–81.:doi:https://doi.org/10.1038/nature03579
- Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH, Fairbrother WJ, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19(2):202–8.:doi:https://doi.org/10.1038/nm.3048